(Q37657468)

21 August 2017

1 reference

title

Pharmaceutical development of microbicide drug products (English)

1 reference

21 August 2017

David R Friend

1

1 reference

21 August 2017

publication date

17 December 2009

1 reference

Pharmaceutical Development and Technology

21 August 2017

published in

1 reference

21 August 2017

volume

15

1 reference

21 August 2017

issue

6

1 reference

21 August 2017

page(s)

562-581

1 reference

HIV disease treatment in the era of HAART.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Microbicides: a new frontier in HIV prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Microbicides: a new approach to preventing HIV and other sexually transmitted infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Men's attitudes towards a potential vaginal microbicide in Zimbabwe, Mexico and the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Women's interest in vaginal microbicides.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Vaginal microbicides for the prevention of HIV transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Vaginal microbicides: a novel approach to preventing sexual transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

The future of HIV prevention: prospects for an effective anti-HIV microbicide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Microbicides for prevention of transmission of sexually transmitted diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Microbicides and other topical strategies to prevent vaginal transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Microbicide drug candidates to prevent HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Topical microbicides. Current status and research considerations for adolescent girls.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Inhibiting sexual transmission of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Vaginal microbicides and the prevention of HIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Clinical development of microbicides for the prevention of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Topical microbicides to prevent HIV: clinical drug development challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Vaginal drug delivery systems for HIV prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Microbicides in India-present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Development pharmaceutics of microbicide formulations. Part I: preformulation considerations and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Development pharmaceutics of microbicide formulations. Part II: formulation, evaluation, and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Microbicide delivery: formulation technologies and strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Recommendations for the clinical development of topical microbicides: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Public health. Regulatory challenges in microbicide development.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Recommendations for the nonclinical development of topical microbicides for prevention of HIV transmission: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Microbicide safety/efficacy studies in animals: macaques and small animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Effect of topical microbicides on infectious human immunodeficiency virus type 1 binding to epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Willingness to use microbicides is affected by the importance of product characteristics, use parameters, and protective properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Microbicide acceptability research: current approaches and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Predictors of using a microbicide-like product among adolescent girls

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

A framework for examining the sustained acceptability of microbicides.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Preferences and practices related to vaginal lubrication: implications for microbicide acceptability and clinical testing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: results of product trials in three cities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Microbicide preference among young women in California

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Microflora changes with the use of a vaginal microbicide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Direct measurement of in-vivo vaginal microbicide levels of PRO 2000 achieved in a human safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Effect of candidate vaginally-applied microbicide compounds on recognition of antigen by CD4+ and CD8+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Microbicides--evaluating multiple formulations of C31G.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Comparative safety evaluation of the candidate vaginal microbicide C31G

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Vaginal and rectal topical microbicide development: safety and efficacy of 1.0% Savvy (C31G) in the pigtailed macaque

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Fourteen-day safety and acceptability study of the universal placebo gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Mucosal irritation potential of personal lubricants relates to product osmolality as detected by the slug mucosal irritation assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

In vitro pre- and post-exposure prophylaxis using HIV inhibitors as microbicides against cell-free or cell-associated HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Dose-ranging phase 1 study of TMC120, a promising vaginal microbicide, in HIV-negative and HIV-positive female volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

The evaluation of the local tolerance of vaginal formulations containing dapivirine using the Slug Mucosal Irritation test and the rabbit vaginal irritation test.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Attenuated infectivity of HIV type 1 from epithelial cells pretreated with a tight-binding nonnucleoside reverse transcriptase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Solid state properties of pure UC-781 and solid dispersions with polyvinylpyrrolidone (PVP K30).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Characterization of cyclodextrin inclusion complexes of the anti-HIV non-nucleoside reverse transcriptase inhibitor UC781

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

In vitro microbicidal activity of the nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781 against NNRTI-resistant human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Is HIV drug resistance a limiting factor in the development of anti-HIV NNRTI and NRTI-based vaginal microbicide strategies?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Blocking of cell-free and cell-associated HIV-1 transmission through human cervix organ culture with UC781.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Preclinical safety assessments of UC781 anti-human immunodeficiency virus topical microbicide formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Glycerol monolaurate prevents mucosal SIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Assessing microbicide acceptability: a comprehensive and integrated approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

The role of men in women's acceptance of an intravaginal gel in a randomized clinical trial in Blantyre, Malawi: a qualitative and quantitative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Erosion of microbicide formulation coating layers: effects of contact and shearing with vaginal fluid or semen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Effects of physiological fluids on physical-chemical characteristics and activity of topical vaginal microbicide products

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

21 January 2018

A vaginal fluid simulant

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Vaginal distribution of Replens and K-Y Jelly using three imaging techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Optical imaging and analysis of human vaginal coating by drug delivery gels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

A randomized trial to determine the distribution of four topical gel formulations in the human vagina.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Distribution of a 3.5-mL (1.0%) C31G vaginal gel using magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

The optimal analysis of MRI data to quantify the distribution of a microbicide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Interpreting properties of microbicide drug delivery gels: analyzing deployment kinetics due to squeezing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Dynamics of HIV neutralization by a microbicide formulation layer: biophysical fundamentals and transport theory

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Use of frozen-thawed cervical tissues in the organ culture system to measure anti-HIV activities of candidate microbicides.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Comparative permeability of various chemical markers through human vaginal and buccal mucosa as well as porcine buccal and mouth floor mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Organotypic human vaginal-ectocervical tissue model for irritation studies of spermicides, microbicides, and feminine-care products

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

The retrocyclin analogue RC-101 prevents human immunodeficiency virus type 1 infection of a model human cervicovaginal tissue construct

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Early events in HIV transmission through a human reconstructed vaginal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Microbicide applicators: understanding design preferences among women in the dominican republic and South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Acceptability and feasibility of Micralax applicators and of methyl cellulose gel placebo for large-scale clinical trials of vaginal microbicides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Microbicide safety and effectiveness: an overview of recent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Assay for establishing whether microbicide applicators have been exposed to the vagina.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Thermoreversible gel formulations containing sodium lauryl sulfate or n-Lauroylsarcosine as potential topical microbicides against sexually transmitted diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

A review of the physical and chemical properties of human semen and the formulation of a semen simulant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

In vitro release of nonoxynol-9 from silicone matrix intravaginal rings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Use of Sno Strip filter-paper wicks for collection of genital-tract samples allows reproducible determination of human immunodeficiency virus type 1 (HIV-1) RNA viral load with a commercial HIV-1 viral load assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Sustained release of microbicides by newly engineered vaginal rings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Development of novel sustained release bioadhesive vaginal tablets of povidone iodine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Phase I safety study of Praneem polyherbal vaginal tablet use among HIV-uninfected women in Pune, India

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Expanded safety study of Praneem polyherbal vaginal tablet among HIV-uninfected women in Pune, India: a phase II clinical trial report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Development and characterization of bioadhesive vaginal films of sodium polystyrene sulfonate (PSS), a novel contraceptive antimicrobial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Water dispersible microbicidal cellulose acetate phthalate film

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Development and evaluation of a thermoreversible ovule formulation of stampidine, a novel nonspermicidal broad-spectrum anti-human immunodeficiency virus microbicide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Synergistic inhibition of HIV-1 infection by combinations of soluble polyanions with other potential microbicides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Conceival, a novel noncontraceptive vaginal vehicle for lipophilic microbicides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

The search for a topical dual action spermicide/microbicide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Effect of a single vaginal administration of levonorgestrel in Carraguard gel on the ovulatory process: a potential candidate for "dual protection" emergency contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Effect of sexual intercourse on the absorption of levonorgestrel after vaginal administration of 0.75 mg in Carraguard gel: a randomized, cross-over, pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Safety analysis of the diaphragm in combination with lubricant or acidifying microbicide gels: effects on markers of inflammation and innate immunity in cervicovaginal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Microbicides and HIV: help or hindrance?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Will microbicide trials yield unbiased estimates of microbicide efficacy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Some design issues in trials of microbicides for the prevention of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

HIV trial doomed by design, say critics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Whither or wither microbicides?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Biomarkers of cervicovaginal inflammation for the assessment of microbicide safety

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Synthetic cervical mucus formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

Safety and Availability of Dapivirine (TMC120) Delivered from an Intravaginal Ring

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450903369879

10.3109/10837450903369879

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference